AKT1 and pancreatic neoplasm: Taken altogether these data strongly suggest that in MiaPaCa-2 pancreatic cancer cells and in the presence of SELN6.0, Akt is likely a downstream target of the SDF-1α-CXCR4 axis rather than under Kras activity.